In addition to being a transporter and an actin scavenger protein, Gc may be of importance for bone formation and in the immune system. After in vitro removal of its galactose and sialic acid residues, Gc is converted to a very potent macrophage-activating factor, Gc-MAF (12) . Administration of Gc-MAF to osteopetrotic rodents reversed their bone and immunological defects, probably by activating osteoclasts as well as macrophages (13) . Finally, together with complement factors C5a and C5a des Arg, Gc may act as a cochemotactic factor in facilitating chemotaxis of neutrophils and monocytes in inflammation (14) (15) .
Despite the diverse and important roles of Gc, only a few methods for measurement of the protein in serum have been evaluated, and little attention has been paid to possible variation in the serum concentration of Gc as a function of phenotype.
We established an immunonephelometric method for quantification of serum The interassay CV for measurement of Gc was 2.6% and 4.6% for 275 and 137 mg/L Gc (n = 22), respectively, as judged from control samples analyzed over a period of 6 months. Sera from two blood donors were used as high (undiluted serum) and low (diluted 1.6:1 with phosphate-buffered saline) controls.
To examine whether our method correctly quantified the serum Gc concentration, based on Gc phenotype, we analyzed four serum samples of each homozygous Gc-type, Gc2-2, Gc1s-1s, and Gc1f-1f, in six dilutions, from undiluted to 1:6. Data were subjected to linear regression analysis. The Gc phenotypes behaved alike (P = 0.291). All samples showed a linear relationship between expected and observed concentrations of Gc (P <0.001), and the slopes and intercepts showed only small deviations from 1 and 0. We determined the Gc phenotype of 586 healthy women not taking any hormonal medications [participants of the DOPS study (16) Other assays for quantifying the serum concentration of Gc include radioimmunoassay (19) , radial immunodiffusion (20) , rocket immunoelectrophoresis (21), and ELISA (22) . These methods are imprecise, technically demanding, time-consuming, or involve the use of isotopic tracers.
The immunonephelometric assay for Gc (1) evaluated in this report therefore seems to be the most useful assay for routine use because it is fully automated and has a low imprecision.
The three genetic types of Gc differ in amino acid sequence (2) and in glycosylation. Gc2 is glycosylated with a terminal galactose, whereas Gc1f and Gc1s contain both galactose and sialic acid (3). These differences may well cause variations in antigenicity and in binding affinity for the Gc antibodies. An important question concerning immunological assays for Gc, therefore, is whether the immunoreactivity of the Gc phenotypes is identical in that specific assay. Ideally one would like to show that equal amounts of each Gc phenotype produce the same signal in the assay. This is, however, impossible because pure Gc is available only as a mixture of the various phenotypes. In our study we chose to examine the linearity of the homozygous Gc types separately. All phenotypes behaved alike when the samples were serially diluted. This indicates that possible differences in immunoreactivity are unlikely to have any practical importance in our assay.
The observed relationship between Gc phenotype and Gc serum concentration is supported by a few previously published smaller studies (Table 1! ) . Constans et al. (23) and Daiger et al. (24) analyzed 100 and 89 persons, respectively, but they did not distinguish between Gc1s and Gc1f.
Braun et al. (25) determined the Gc concentrations of the three homozygous phenotypes (the number of participants was not specified), but their result for Gc1f-1f was much higher than ours. A possible explanation is that their assay recognized Gc1f-1f better than the other phenotypes.
The differences in Gc concentration among the Gc types are theoretically attributable to variations in either the production rate or the metabolic rate.
From the glycosylation pattern of the Gc proteins one would expect Gc2-2 to be metabolized faster than the sialylated form, Gc1-1. Interestingly, the lowest serum concentrations were observed for Gc2-2. An increased metabolic rate for Gc2-2 is further supported by a study by Kawakami et al. (26) , who injected radioactive Gc into four healthy young men. The metabolic rate of Gc was higher in the person with the Gc2-2 phenotype receiving Gc2 than in the person with Gc1-1 receiving Gc1 (32.6% vs 25.0% per day).
The clinical significance of the differences in serum Gc concentration among Gc phenotypes is yet to be investigated. Regarding the actin scavenging system, it is hardly crucial. The half-life of Gc-actin complexes is only 30 min, suggesting that differences in the initial concentrations of Gc are of minor importance. Regarding interpretation of serum concentrations of substances carried by Gc, notably vitamin D, it may well be important to know the Gc concentration and, possibly, the Gc phenotype.
In conclusion, we evaluated an automated assay for quantification of Gc and showed that the serum concentration of Gc depends on the Gc phenotype. http://clinchem.aaccjnls.org/content/47/4/753 Mean serum Gc concentrations (bars, SE), in mg/L, for the six Gc phenotypes (A) and for the three groups of Gc phenotypes (B).
The number of persons examined is indicated in parentheses below each phenotype.
Table 1.
Gc concentration.
